Fortress Biotech Inc (FBIO) — Cash Flow-to-Debt Ratio
Fortress Biotech Inc (FBIO) has a Cash Flow-to-Debt Ratio of -0.10x as of December 2025, meaning its operating cash flow of $-12.54 Million could theoretically repay 0% of its total liabilities ($123.36 Million) in one year. See FBIO free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Fortress Biotech Inc Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Fortress Biotech Inc across 17 annual periods. For the full cash flow conversion analysis, see Fortress Biotech Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Fortress Biotech Inc (2009–2025)
Year-by-year debt coverage analysis for Fortress Biotech Inc. Check Fortress Biotech Inc (FBIO) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.53x | $-65.78 Million | $123.36 Million | ▲ +3.0% |
| 2024 | -0.55x | $-80.19 Million | $145.87 Million | ▲ +28.9% |
| 2023 | -0.77x | $-128.22 Million | $165.94 Million | ▼ -5.2% |
| 2022 | -0.73x | $-179.40 Million | $244.28 Million | ▼ -7.5% |
| 2021 | -0.68x | $-116.54 Million | $170.63 Million | ▼ -11.3% |
| 2020 | -0.61x | $-83.68 Million | $136.41 Million | ▲ +0.6% |
| 2019 | -0.62x | $-94.96 Million | $153.89 Million | ▲ +24.3% |
| 2018 | -0.82x | $-98.85 Million | $121.25 Million | ▼ -19.7% |
| 2017 | -0.68x | $-85.43 Million | $125.45 Million | ▼ -30.5% |
| 2016 | -0.52x | $-45.81 Million | $87.76 Million | ▲ +12.0% |
| 2015 | -0.59x | $-20.38 Million | $34.34 Million | ▲ +31.7% |
| 2014 | -0.87x | $-16.33 Million | $18.81 Million | ▲ +43.5% |
| 2013 | -1.54x | $-29.65 Million | $19.30 Million | ▼ -25.5% |
| 2012 | -1.22x | $-23.19 Million | $18.96 Million | ▲ +52.6% |
| 2011 | -2.58x | $-10.95 Million | $4.24 Million | ▲ +29.1% |
| 2010 | -3.64x | $-5.68 Million | $1.56 Million | ▼ -1724.1% |
| 2009 | -0.20x | $-2.35 Million | $11.78 Million | — |